Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester

Details for Australian Patent Application No. 2002257817 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Schindler, Thomas; Schroeder, Marco; Maeder, Karsten; Martin, Rainer Eugen; Raab, Susanne; Scheibler, Lukas Christoph

Agent Spruson & Ferguson

Pub. Number AU-B-2002257817

PCT Pub. Number WO2002/098412

Priority 01113793.2 06.06.01 EP

Filing date 29 May 2002

Wipo publication date 16 December 2002

Acceptance publication date 18 August 2005

International Classifications

A61K 031/365 - Lactones

A61K 047/26 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 009/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61P 003/04 Drugs for disorders of the metabolism

Event Publications

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002257817

18 August 2005 Application Accepted

  Published as AU-B-2002257817

15 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002257818-METHOD FOR PRODUCING PERBENZYLATED 1-O-GLYCOSIDES

2002257816-BOTTLE-BRUSH TYPE COATINGS WITH ENTANGLED HYDROPHILIC POLYMER